Data / Form D filings / 20/20 GeneSystems, Inc.
20/20 GeneSystems, Inc.: Form D filings
20/20 GeneSystems, Inc., a biotechnology company in Gaithersburg, MD, filed 5 Form D notices with the SEC between 2015 and 2025. The latest, on February 26, 2025, reports $70,000 sold of a $3 million offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 15810 Gaither Road, Suite 235, Gaithersburg, MD, 20877
- Phone
- (240) 453-6339
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1139685
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 26, 2025 | New notice | $3,000,000 | $70,000 | $2,930,000 | 3 | Jan 21, 2025 | sec.gov |
| Feb 19, 2016 | Amendment | $4,000,000 | $2,513,413 | $1,486,587 | 66 | Oct 31, 2014 | sec.gov |
| Feb 4, 2016 | New notice | $3,000,000 | $2,000,000 | $1,000,000 | 1 | Jan 28, 2016 | sec.gov |
| Oct 30, 2015 | Amendment | $4,000,000 | $2,158,413 | $1,841,587 | 49 | Oct 31, 2014 | sec.gov |
| Sep 22, 2015 | New notice | $4,000,000 | $2,037,014 | $1,962,986 | 45 | Oct 31, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jonathan Cohen | Executive Officer, Director | |
| Prasanth G Reddy | Director | |
| John G Compton | Director | |
| John W. Rollins | Director | |
| Wei G Lu | Director | |
| Richard M. Cohen | Director | |
| Anne Shiflett | Executive Officer | |
| Jiminy Zhou | Executive Officer | |
| Michael A Ross | Director |
Other biotechnology companies in Maryland that filed recently
- Accufy Diagnostics, Inc. $2 million · Oct 28, 2026
- OS Therapies Inc $7.2 million · Oct 23, 2026
- Kaigene, Inc. $55 million · Oct 14, 2026
- Templar Nova, Inc. $7 million · Oct 7, 2026
- Monocacy Therapeutics Inc. $25,000 · Oct 7, 2026
- Seraxis Holdings, Inc. $10 million · Sep 24, 2026
Every Form D from the week of Feb 24, 2025 · All recent filings in Maryland · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what 20/20 GeneSystems, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.